v3.26.3
UNAUDITED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY - USD ($)
Total
Common Stock
Treasury Stock
Additional Paid in Capital
Accumulated Deficit
Stockholders’ equity, beginning balance (in shares) at Dec. 29, 2024   11,039,000      
Stockholders’ equity, beginning balance at Dec. 29, 2024 $ 82,269,000 $ 110,000 $ (57,000) $ 70,260,000 $ 11,956,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share-based compensation 168,000     168,000  
Share-based compensation from discontinued operations 18,000     18,000  
Issuance of restricted shares (in shares)   53,000      
Issuance of restricted shares 0 $ 1,000   (1,000)  
Issuance of ESPP Shares (shares)   17,000      
Issuance of ESPP shares 87,000     87,000  
Net income (loss) (722,000)       (722,000)
Stockholders’ equity, ending balance (in shares) at Mar. 30, 2025   11,109,000      
Stockholders’ equity, ending balance at Mar. 30, 2025 81,820,000 $ 111,000 (57,000) 70,532,000 11,234,000
Stockholders’ equity, beginning balance (in shares) at Dec. 29, 2024   11,039,000      
Stockholders’ equity, beginning balance at Dec. 29, 2024 82,269,000 $ 110,000 (57,000) 70,260,000 11,956,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (10,270,000)        
Stockholders’ equity, ending balance (in shares) at Sep. 28, 2025   11,200,000      
Stockholders’ equity, ending balance at Sep. 28, 2025 50,686,000 $ 112,000 (57,000) 71,345,000 (20,714,000)
Stockholders’ equity, beginning balance (in shares) at Mar. 30, 2025   11,109,000      
Stockholders’ equity, beginning balance at Mar. 30, 2025 81,820,000 $ 111,000 (57,000) 70,532,000 11,234,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share-based compensation 137,000     137,000  
Share-based compensation from discontinued operations 18,000     18,000  
Issuance of restricted shares (in shares)   35,000      
Issuance of restricted shares 0 $ 1,000   (1,000)  
Issuance of ESPP Shares (shares)   15,000      
Issuance of ESPP shares 47,000     47,000  
Net income (loss) (3,736,000)       (3,736,000)
Stockholders’ equity, ending balance (in shares) at Jun. 29, 2025   11,159,000      
Stockholders’ equity, ending balance at Jun. 29, 2025 78,286,000 $ 112,000 (57,000) 70,733,000 7,498,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share-based compensation 545,000     545,000  
Share-based compensation from discontinued operations 67,000     67,000  
Issuance of restricted shares (in shares)   41,000      
Cash dividend declared (22,400,000)       (22,400,000)
Net income (loss) (5,812,000)       (5,812,000)
Stockholders’ equity, ending balance (in shares) at Sep. 28, 2025   11,200,000      
Stockholders’ equity, ending balance at Sep. 28, 2025 50,686,000 $ 112,000 (57,000) 71,345,000 (20,714,000)
Stockholders’ equity, beginning balance (in shares) at Dec. 28, 2025   11,227,000      
Stockholders’ equity, beginning balance at Dec. 28, 2025 48,105,000 $ 112,000 (1,578,000) 71,445,000 (21,874,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share-based compensation 230,000     230,000  
Issuance of restricted shares (in shares)   17,000      
Repurchase of common stock, 170,862 shares (873,000)   (873,000)    
Net income (loss) (471,000)       (471,000)
Stockholders’ equity, ending balance (in shares) at Mar. 29, 2026   11,244,000      
Stockholders’ equity, ending balance at Mar. 29, 2026 46,991,000 $ 112,000 (2,451,000) 71,675,000 (22,345,000)
Stockholders’ equity, beginning balance (in shares) at Dec. 28, 2025   11,227,000      
Stockholders’ equity, beginning balance at Dec. 28, 2025 48,105,000 $ 112,000 (1,578,000) 71,445,000 (21,874,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (961,000)        
Stockholders’ equity, ending balance (in shares) at Sep. 27, 2026   11,279,000      
Stockholders’ equity, ending balance at Sep. 27, 2026 46,404,000 $ 113,000 (2,913,000) 72,039,000 (22,835,000)
Stockholders’ equity, beginning balance (in shares) at Mar. 29, 2026   11,244,000      
Stockholders’ equity, beginning balance at Mar. 29, 2026 46,991,000 $ 112,000 (2,451,000) 71,675,000 (22,345,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share-based compensation 187,000     187,000  
Issuance of restricted shares (in shares)   18,000      
Issuance of restricted shares 0 $ 1,000   (1,000)  
Repurchase of common stock, 170,862 shares (293,000)   (293,000)    
Net income (loss) (834,000)       (834,000)
Stockholders’ equity, ending balance (in shares) at Jun. 28, 2026   11,262,000      
Stockholders’ equity, ending balance at Jun. 28, 2026 46,051,000 $ 113,000 (2,744,000) 71,861,000 (23,179,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share-based compensation 178,000     178,000  
Issuance of restricted shares (in shares)   17,000      
Repurchase of common stock, 170,862 shares (169,000)   (169,000)    
Net income (loss) 344,000       344,000
Stockholders’ equity, ending balance (in shares) at Sep. 27, 2026   11,279,000      
Stockholders’ equity, ending balance at Sep. 27, 2026 $ 46,404,000 $ 113,000 $ (2,913,000) $ 72,039,000 $ (22,835,000)